Drawing on a background in drug development and CMC (chemistry, manufacturing, and controls), Ill walk through how Melanotan II actually works in the body, how long it tends to last in your system, and what that means for dose timing and safety
The use of peptides in chronic disease treatment is a rapidly expanding area of research, with numerous clinical trials underway to explore their full potential
Ke L, Zhong C, Chen Z et al (2023) Tanshinone I: pharmacological activities, molecular mechanisms against diseases and future perspectives
Uh, Rhonda, thanks so much for your time
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial